NKGen Biotech Statistics
Total Valuation
NKGen Biotech has a market cap or net worth of $18.82 million. The enterprise value is $38.47 million.
| Market Cap | 18.82M |
| Enterprise Value | 38.47M |
Important Dates
The last earnings date was Tuesday, April 16, 2024.
| Earnings Date | Apr 16, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
NKGen Biotech has 21.89 million shares outstanding. The number of shares has increased by 142.70% in one year.
| Shares Outstanding | 21.89M |
| Shares Change (YoY) | +142.70% |
| Shares Change (QoQ) | +15.14% |
| Owned by Insiders (%) | 60.49% |
| Owned by Institutions (%) | 29.84% |
| Float | 6.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.05
| Current Ratio | 0.05 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -110.34 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -416.00% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.28M |
| Employee Count | 65 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NKGen Biotech has paid $7,000 in taxes.
| Income Tax | 7,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -91.56% in the last 52 weeks. The beta is 0.44, so NKGen Biotech's price volatility has been lower than the market average.
| Beta (1Y) | 0.44 |
| 52-Week Price Change | -91.56% |
| 50-Day Moving Average | 1.52 |
| 200-Day Moving Average | 4.85 |
| Relative Strength Index (RSI) | 31.13 |
| Average Volume (30 Days) | 2,858,011 |
Short Selling Information
The latest short interest is 621,557, so 2.84% of the outstanding shares have been sold short.
| Short Interest | 621,557 |
| Short Previous Month | 843,935 |
| Short % of Shares Out | 2.84% |
| Short % of Float | 9.42% |
| Short Ratio (days to cover) | 2.08 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -29.75M |
| Pretax Income | -82.95M |
| Net Income | -82.95M |
| EBITDA | -80.64M |
| EBIT | -82.20M |
| Earnings Per Share (EPS) | -$5.38 |
Balance Sheet
The company has $276,000 in cash and $19.92 million in debt, giving a net cash position of -$19.65 million or -$0.90 per share.
| Cash & Cash Equivalents | 276,000 |
| Total Debt | 19.92M |
| Net Cash | -19.65M |
| Net Cash Per Share | -$0.90 |
| Equity / Book Value | -58.69M |
| Book Value Per Share | -2.68 |
| Working Capital | -37.52M |
Cash Flow
In the last 12 months, operating cash flow was -$21.95 million and capital expenditures -$48,000, giving a free cash flow of -$22.00 million.
| Operating Cash Flow | -21.95M |
| Capital Expenditures | -48,000 |
| Free Cash Flow | -22.00M |
| FCF Per Share | -$1.43 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NKGen Biotech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -142.70% |
| Shareholder Yield | -142.70% |
| Earnings Yield | -440.67% |
| FCF Yield | -116.85% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |